Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
11/2005
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108361A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005US20050256162 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/17/2005US20050256106 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/17/2005US20050255040 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565632A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/16/2005EP1594869A2 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
11/16/2005EP1594860A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005CN1227251C Carbamates derived from arylalkylamines
11/15/2005CA2167183C Process for making hiv protease inhibitors
11/10/2005WO2005105795A1 Process for producing solifenacin or its salt
11/10/2005WO2005104745A2 Muscarinic acetylcholine receptor antagonists
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005CA2755954A1 Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists
11/10/2005CA2692561A1 Method for producing solifenacin or salts thereof
11/09/2005EP1592685A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245531 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, senile dementia, AIDS dementia, Pick's Disease, dementia associated with Down's syndrome; alpha 7 nAChR ligands modulators
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/01/2005US6960666 administering an azabicyclo or azatricyclo compound to treat inflammatory diseases such as asthma
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
10/2005
10/27/2005WO2005100351A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100343A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005DE102004018795A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005CA2563010A1 Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-1-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
10/27/2005CA2562526A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005CA2560346A1 Polycyclic pyridines as potassium ion channel modulators
10/26/2005CN1688573A Pyrrole based inhibitors of glycogen synthase kinase 3
10/20/2005WO2005046590A3 Methods for synthesizing quinolinone compounds
10/20/2005US20050234095 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
10/20/2005US20050234092 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/19/2005EP1586566A1 P-toluenosulfonate salt of N-Methyl-N-(3,5-dimathoxy-2,4,6-triazinyl-1-)-morpholine and related compounds for use as condensing reagent in peptide synthesis
10/19/2005CN1684962A Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/13/2005WO2005095353A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005WO2005095346A1 3-((hetero)arylsulfonyl)-8-` (aminoalkyl)oxy!quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228034 treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease; for treating, ameliorating or preventing a CB1 receptor inverse-agonist mediated appetite related obesity related or metabolism related syndrome, disorder or disease
10/13/2005US20050227336 Methods for producing optically active alcohols
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/11/2005US6953855 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
10/06/2005WO2005092890A2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
10/06/2005WO2005092889A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005CA2560741A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
10/05/2005CN1678611A Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
10/05/2005CN1678610A New quinuclidine amide derivatives
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
09/2005
09/29/2005WO2005090342A1 New quaternized quinuclidine esters
09/29/2005WO2005090341A1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2005WO2005051917A9 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
09/29/2005CA2560157A1 New quaternized quinuclidine esters
09/28/2005EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675204A 2-heteroaryl carboxamides
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1220692C Process for preparing cephalotaxane derivatives
09/28/2005CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/27/2005US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
09/27/2005US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087231A1 Solifenacin-containing composition
09/22/2005US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209272 Novel quinuclidine derivatives and medicinal compositions containing the same
09/22/2005US20050209247 Lactate salt of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; improved water solubility and physicochemical properties (e.g., stability, hygroscopicity, crystallinity, and compactibility); vascular endothelial growth factor receptor tyrosine kinase inhibitors
09/22/2005US20050209236 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory
09/22/2005US20050209232 Useful for treating inflammatory, immunological, and integrin-mediated disorders such as inflammatory bowel disease; 2-(3,3-Diisopropyl-ureido)-3-[4-(5-methoxy-2-methyl-3-oxo-2,3-dihydro-pyridazin-4-yl)-phenyl]-propionic acid for example
09/22/2005CA2560080A1 Solifenacin-containing composition
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203125 Treating pseudobulbar affect or emotional lability; nervous system, brain, and neurodegenerative disorders; analgesics; neuropathic pain; dextromethorphan hydrobromide and quinidine sulfate
09/15/2005US20050203101 Benzimidazole quinolinones and uses thereof
09/14/2005CN1218946C Isoquinuclidine derivative, process for producing same, and medicinal compsn. contg. same
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2004108636A3 Isotopically labeled chemically stable reagents and process for the synthesis thereof
09/08/2005US20050197363 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1217943C New use and novel N-azabicyclo-amide derivatives
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/01/2005WO2005066167A3 3-quinuclidinyl heteroatom bridged biaryl derivatives
09/01/2005WO2005066166A3 3-quinuclidinyl amino-substituted biaryl derivatives
09/01/2005WO2005066163A3 Thiophene derivatives as chk 1 inihibitors
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
08/2005
08/31/2005CN1662542A Heterocyclic compounds
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 58